Filing Details
Beam Therapeutics Inc. (NASDAQ:BEAM) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 04, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:BEAM
Beam Therapeutics Inc. (BEAM) Files Quarterly Report for Q0
Filing Details Beam Therapeutics Inc. (NASDAQ:BEAM) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 04, 2026. The Healthcare company…
Market Context
Beam Therapeutics Inc.'s stock currently trades at $28.35 with a market capitalization of $2.8B.
The 10-Q provides Beam Therapeutics Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Beam Therapeutics Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BEAM Stock Page
Frequently Asked Questions
Where can I read BEAM's SEC filings?
Browse all filings on our BEAM SEC filings page.
What types of SEC filings does Beam Therapeutics Inc. file?
Public companies like Beam Therapeutics Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
